{"id":"succinic-acid","rwe":[],"_fda":{"id":"7e90559f-51b5-36ff-e053-2a91aa0a9b17","set_id":"119a205d-0074-48ff-ac78-e2300db45227","openfda":{"nui":["N0000193618","M0001797","N0000185375","N0000185371","N0000175629","N0000184306","M0000728","M0006342","M0016962","M0022575","N0000185017"],"upc":["0317089075202"],"unii":["8ID597Z82X","73Y7P0K73Y","OF5471ZHRR","8L70Q75FXE","PQ6CK8PD0R","CUQ3A77YXI","L7A49804ZQ","N487KM8COK","0UV74P3R0J","SAA04E81UX","K848JZ4886","88XHZ13131","33X04XA5AT","0E53J927NA","817L1N4CKP","VZ3U1H7Q5B","O138UB266J","68Y4CF58BV","TLM2976OFR","6CA025Y4FG","POD38AIF08","AB6MNQ6J6L","398IYQ16YV","9928MC12VO","M572600E5P"],"route":["ORAL"],"spl_id":["7e90559f-51b5-36ff-e053-2a91aa0a9b17"],"brand_name":["OMEOSPORT"],"spl_set_id":["119a205d-0074-48ff-ac78-e2300db45227"],"package_ndc":["17089-075-20"],"product_ndc":["17089-075"],"generic_name":[".ALPHA.-KETOGLUTARIC ACID - ACONITIC ACID, CIS - ADENOSINE TRIPHOSPHATE - ALPHA LIPOIC ACID - ASCORBIC ACID - ASIAN GINSENG - BARIUM CATION - BEET - CEROUS OXALATE NONAHYDRATE - COENZYME A - CYSTEINE - FUMARIC ACID - LACTIC ACID, DL - MAGNESIUM CARBONATE - MALIC ACID - MANGANESE PHOSPHATE, DIBASIC - PORK - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SUCCINIC ACID - SUS SCROFA ADRENAL GLAND - THIAMINE HYDROCHLORIDE - SUS SCROFA EMBRYO -"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Ascorbic Acid [CS]","Allergens [CS]","Dietary Proteins [CS]","Plant Proteins [CS]","Vegetable Proteins [CS]"],"pharm_class_pe":["Increased Histamine Release [PE]","Cell-mediated Immunity [PE]"],"substance_name":[".ALPHA.-KETOGLUTARIC ACID",".ALPHA.-LIPOIC ACID","ACONITIC ACID, (Z)-","ADENOSINE TRIPHOSPHATE","ASCORBIC ACID","ASIAN GINSENG","BARIUM OXALOSUCCINATE","BEET","CEROUS OXALATE NONAHYDRATE","COENZYME A","CYSTEINE","FUMARIC ACID","LACTIC ACID","MAGNESIUM CARBONATE","MALIC ACID","MANGANESE PHOSPHATE, DIBASIC","PORK","PYRIDOXINE HYDROCHLORIDE","RIBOFLAVIN","SODIUM DIETHYL OXALACETATE","SODIUM PYRUVATE","SUCCINIC ACID","SUS SCROFA ADRENAL GLAND","SUS SCROFA EMBRYO","THIAMINE HYDROCHLORIDE"],"pharm_class_epc":["Vitamin C [EPC]","Non-Standardized Plant Allergenic Extract [EPC]","Non-Standardized Food Allergenic Extract [EPC]"],"manufacturer_name":["Guna spa"],"is_original_packager":[true]},"purpose":["USES For the temporary relief of symptoms related to athletic training and exertion such as: Muscle cramps Sore muscles Lack of endurance"],"version":"2","warnings":["WARNINGS Stop use and ask doctor if symptoms persist more than 5 days or worsen. If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children."],"questions":["QUESTIONS Questions?: info@gunainc.com tel. (484) 223-3500"],"effective_time":"20181221","active_ingredient":["ACTIVE INGREDIENTS/PURPOSE ADENOSINTRIPHOSPHATE 8X CELL METABOLISM ALPHA-KETOGLUTARIC ACID 6X DETOXIFICATION ALPHA-LIPOIC AC 6X DETOXIFICATION ASCORBIC ACID 4X CELL METABOLISM BARIUM OXALOSUCCINATE 6X DETOXIFICATION BETA VULGARIS 2X CELL METABOLISM CERIUM OXALICUM 6X CELL METABOLISM CIS-ACONITIC ACID 6X CELL METABOLISM COENZYME A 6X CELL METABOLISM CYSTEINUM 6X CELL METABOLISM EMBRYO EXTRACT 6X CELL METABOLISM FUMARICUM ACIDUM 6X ANTI-INFLAMMATORY GINSENG 3X DETOXIFICATION GLANDULA SUPRARENALIS 10X HORMONAL REGULATION LACTICUM ACIDUM 8X CELL METABOLISM MAGNESIUM CARBONATE 2X TIREDNESS MALIC ACID 6X CELL METABOLISM MANGANUM PHOSPHORICUM 6X TIREDNESS MUSCLE TISSUE 6X MUSCLE METABOLISM NATRUM OXALACETICUM 6X CELL METABOLISM NATRUM PYRUVICUM 6X CELL METABOLISM PYRIDOXINUM HYDROCHLORICUM 6X METABOLIC SUPPORT RIBOFLAVINUM 6X CELL METABOLISM SUCCINICUM ACIDUM 6X CELL METABOLISM THIAMINUM HYDROCHLORICUM 4X METABOLIC SUPPORT"],"inactive_ingredient":["Inactive ingredient: Sucrose."],"indications_and_usage":["Directions: Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue. Allow to dissolve Take 15 minutes before meals."],"dosage_and_administration":["DIRECTIONS Take 15 minutes before meals Adults and children 12 years and older 5 pellets 3 times per day Children between 12 years and 6 years of age 3 pellets 3 times per day Children under 6 years 1 pellet 3 times per day to be dissolved into a little water"],"spl_product_data_elements":["OMEOSPORT .ALPHA.-KETOGLUTARIC ACID - ACONITIC ACID, CIS - ADENOSINE TRIPHOSPHATE - ALPHA LIPOIC ACID - ASCORBIC ACID - ASIAN GINSENG - BARIUM CATION - BEET - CEROUS OXALATE NONAHYDRATE - COENZYME A - CYSTEINE - FUMARIC ACID - LACTIC ACID, DL - MAGNESIUM CARBONATE - MALIC ACID - MANGANESE PHOSPHATE, DIBASIC - PORK - PYRIDOXINE HYDROCHLORIDE - RIBOFLAVIN - SODIUM DIETHYL OXALACETATE - SODIUM PYRUVATE - SUCCINIC ACID - SUS SCROFA ADRENAL GLAND - THIAMINE HYDROCHLORIDE - SUS SCROFA EMBRYO - SUCROSE ADENOSINE TRIPHOSPHATE ADENOSINE TRIPHOSPHATE .ALPHA.-KETOGLUTARIC ACID .ALPHA.-KETOGLUTARIC ACID .ALPHA.-LIPOIC ACID .ALPHA.-LIPOIC ACID ASCORBIC ACID ASCORBIC ACID BARIUM OXALOSUCCINATE BARIUM CATION BEET BEET CEROUS OXALATE NONAHYDRATE CEROUS CATION ACONITIC ACID, (Z)- ACONITIC ACID, (Z)- COENZYME A COENZYME A CYSTEINE CYSTEINE SUS SCROFA EMBRYO SUS SCROFA EMBRYO FUMARIC ACID FUMARIC ACID ASIAN GINSENG ASIAN GINSENG SUS SCROFA ADRENAL GLAND SUS SCROFA ADRENAL GLAND LACTIC ACID LACTIC ACID MAGNESIUM CARBONATE CARBONATE ION MALIC ACID MALIC ACID MANGANESE PHOSPHATE, DIBASIC MANGANESE CATION (2+) PORK PORK SODIUM DIETHYL OXALACETATE DIETHYL OXALACETATE SODIUM PYRUVATE PYRUVIC ACID PYRIDOXINE HYDROCHLORIDE PYRIDOXINE RIBOFLAVIN RIBOFLAVIN SUCCINIC ACID SUCCINIC ACID THIAMINE HYDROCHLORIDE THIAMINE ION white"],"pregnancy_or_breast_feeding":["PREGNANCY If pregnant or breast-feeding ask a health professional before use."],"keep_out_of_reach_of_children":["WARNINGS Keep out of reach of children"],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL 5USBIO-Omeosport-rev04-110718"]},"tags":[{"label":"succinic acid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Egl nine homolog 1","category":"target"},{"label":"EGLN1","category":"gene"},{"label":"SUCNR1","category":"gene"},{"label":"Oral","category":"route"},{"label":"Tablet","category":"form"},{"label":"Active","category":"status"},{"label":"Iron deficiency anemia","category":"indication"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"ANAEMIA","source":"FDA FAERS","actionTaken":"44 reports"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"42 reports"},{"date":"","signal":"ASTHENIA","source":"FDA FAERS","actionTaken":"40 reports"},{"date":"","signal":"RENAL FAILURE","source":"FDA FAERS","actionTaken":"39 reports"},{"date":"","signal":"ANXIETY","source":"FDA FAERS","actionTaken":"38 reports"},{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"38 reports"},{"date":"","signal":"CARDIAC FAILURE CONGESTIVE","source":"FDA FAERS","actionTaken":"35 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"35 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"35 reports"},{"date":"","signal":"EMOTIONAL DISTRESS","source":"FDA FAERS","actionTaken":"27 reports"}],"commonSideEffects":[],"contraindications":["Anemia due to enzyme deficiency","Diverticular disease","Gastroenteritis","Hb SS disease","Hemochromatosis","Hemolytic anemia","Hemosiderosis","Peptic ulcer","Primary hyperoxaluria","Repeated Blood Transfusions","Ulcerative colitis"]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=SUCCINIC ACID","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:55:22.275847+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:55:28.913016+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SUCCINIC ACID","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:55:29.657352+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:55:20.042876+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:55:20.043045+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:55:20.043056+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T01:55:31.575665+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL576/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:55:30.562569+00:00"}},"allNames":"butanedioic acid","offLabel":[],"synonyms":["butanedioic acid","succinic acid"],"timeline":[],"approvals":[],"brandName":"Butanedioic Acid","ecosystem":[{"indication":"Iron deficiency anemia","otherDrugs":[{"name":"cyanocobalamin","slug":"cyanocobalamin","company":""},{"name":"docusate sodium","slug":"docusate-sodium","company":""},{"name":"ferric carboxymaltose","slug":"ferric-carboxymaltose","company":"Luitpold"},{"name":"ferric citrate","slug":"ferric-citrate","company":"Keryx Biopharms"}],"globalPrevalence":null}],"mechanism":{"target":"Egl nine homolog 1","targets":[{"gene":"EGLN1","source":"DrugCentral","target":"Egl nine homolog 1","protein":"Egl nine homolog 1"},{"gene":"SUCNR1","source":"DrugCentral","target":"Succinate receptor 1","protein":"Succinate receptor 1"}],"modality":"Small Molecule","drugClass":"Vitamin C [EPC]","explanation":"","oneSentence":"","technicalDetail":"Succinic acid acts as a competitive inhibitor of the Egl nine homolog 1 enzyme, thereby reducing its activity and increasing iron levels in the body."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2487","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=SUCCINIC%20ACID","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=SUCCINIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:43:23.422662","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:55:33.587985+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"daprodustat","drugSlug":"daprodustat","fdaApproval":"2023-02-01","patentExpiry":"Mar 13, 2038","patentStatus":"Patent protected","relationship":"same-target"}],"genericName":"succinic acid","indications":{"approved":[{"name":"Iron deficiency anemia","source":"DrugCentral","snomedId":87522002,"regulator":"FDA","eligibility":"patients with iron deficiency"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"daprodustat","brandName":"daprodustat","genericName":"daprodustat","approvalYear":"2023","relationship":"same-target"}],"trialDetails":[{"nctId":"NCT07391774","phase":"PHASE3","title":"Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-07-07","conditions":["Anatomic Stage II Breast Cancer AJCC v8","Anatomic Stage IIIA Breast Cancer AJCC v8","Anatomic Stage IIIC Breast Cancer AJCC v8","Estrogen Receptor-Positive Breast Carcinoma","HER2-Negative Breast Carcinoma"],"enrollment":1978,"completionDate":"2029-07-31"},{"nctId":"NCT07490067","phase":"PHASE4","title":"Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score","status":"NOT_YET_RECRUITING","sponsor":"University of Michigan","startDate":"2026-04","conditions":["Heart Failure With Reduced Ejection Fraction"],"enrollment":100,"completionDate":"2029-07"},{"nctId":"NCT04930237","phase":"","title":"RELISTOR's Effects on Opioid-Induced Constipation","status":"WITHDRAWN","sponsor":"Methodist Health System","startDate":"2021-07-01","conditions":["OIC"],"enrollment":0,"completionDate":"2022-04-22"},{"nctId":"NCT07060404","phase":"PHASE2,PHASE3","title":"Postpartum 8-aminoquinoline Breast Milk Study","status":"NOT_YET_RECRUITING","sponsor":"Curtin University","startDate":"2026-04","conditions":["Drug Pharmacokinetics in Healthy Volunteers"],"enrollment":60,"completionDate":"2027-05"},{"nctId":"NCT07052162","phase":"PHASE4","title":"Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children","status":"RECRUITING","sponsor":"Curtin University","startDate":"2025-10-20","conditions":["Pharmacokinetics of Tafenoquine"],"enrollment":30,"completionDate":"2026-03"},{"nctId":"NCT07473310","phase":"PHASE4","title":"Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2025-11-11","conditions":["Overactive Bladder (OAB)","Urge Incontinence"],"enrollment":70,"completionDate":"2027-12"},{"nctId":"NCT02068586","phase":"PHASE2","title":"Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2014-11-19","conditions":["Ciliary Body and Choroid Melanoma, Medium/Large Size","Ciliary Body and Choroid Melanoma, Small Size","Iris Melanoma","Stage I Intraocular Melanoma","Stage IIA Intraocular Melanoma","Stage IIB Intraocular Melanoma","Stage IIIA Intraocular Melanoma","Stage IIIB Intraocular Melanoma","Stage IIIC Intraocular Melanoma","Stage I Uveal Melanoma AJCC V7","Stage II Uveal Melanoma AJCC V7","Stage III Uveal Melanoma AJCC V7"],"enrollment":210,"completionDate":"2026-12-31"},{"nctId":"NCT05292664","phase":"PHASE1","title":"Venetoclax Basket Trial for High Risk Hematologic Malignancies","status":"RECRUITING","sponsor":"Andrew E. Place, MD","startDate":"2023-03-29","conditions":["Myelodysplastic Syndromes, de Novo","Myelodysplastic Syndromes, Secondary","Myelodysplastic Syndromes, Previously Treated","Treatment-Related Acute Myeloid Leukemia","Therapy-Related Myelodysplastic Syndrome","Acute Lymphoblastic Leukemia, in Relapse","Acute Lymphoblastic Leukemia With Failed Remission","Lymphoblastic Lymphoma, in Relapse","Lymphoblastic Lymphoma, Refractory","Acute Leukemia of Ambiguous Lineage in Relapse","Acute Leukemia of Ambiguous Lineage"],"enrollment":30,"completionDate":"2030-07-02"},{"nctId":"NCT01530373","phase":"PHASE2","title":"Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients","status":"RECRUITING","sponsor":"University of Arkansas","startDate":"2012-02","conditions":["Hot Flashes","Breast Cancer"],"enrollment":110,"completionDate":"2028-09"},{"nctId":"NCT03630991","phase":"PHASE1","title":"Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-10-11","conditions":["Acute Myeloid Leukemia","Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome","Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive","Chronic Myelogenous Leukemia, BCR-ABL1 Positive","High Risk Myelodysplastic Syndrome","Myelodysplastic Syndrome","Myelodysplastic/Myeloproliferative Neoplasm","Myeloproliferative Neoplasm","Recurrent Acute Myeloid Leukemia","Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive","Recurrent Myelodysplastic Syndrome","Recurrent Myelodysplastic/Myeloproliferative Neoplasm","Refractory Acute Myeloid Leukemia","Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive","Refractory Myelodysplastic Syndrome","Secondary Acute Myeloid Leukemia","Secondary Myelodysplastic Syndrome","Very High Risk Myelodysplastic Syndrome"],"enrollment":58,"completionDate":"2027-04-30"},{"nctId":"NCT07298993","phase":"PHASE4","title":"Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2026-02-02","conditions":["Heart Failure","HFpEF","HFpEF - Heart Failure With Preserved Ejection Fraction"],"enrollment":240,"completionDate":"2029-04"},{"nctId":"NCT04438382","phase":"PHASE2","title":"Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis","status":"TERMINATED","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2021-01-07","conditions":["Hematopoietic and Lymphoid Cell Neoplasm","Malignant Solid Neoplasm","Steroid-Refractory Pneumonitis"],"enrollment":1,"completionDate":"2023-12-21"},{"nctId":"NCT06078696","phase":"PHASE1,PHASE2","title":"Siplizumab for Sickle Cell Disease Transplant","status":"TERMINATED","sponsor":"Columbia University","startDate":"2023-09-28","conditions":["Anemia, Sickle Cell"],"enrollment":1,"completionDate":"2025-12-11"},{"nctId":"NCT06247787","phase":"PHASE1","title":"A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-02-04","conditions":["Recurrent Childhood Acute Myeloid Leukemia","Recurrent Childhood Myelodysplastic Syndrome","Recurrent Juvenile Myelomonocytic Leukemia","Refractory Childhood Acute Myeloid Leukemia","Refractory Childhood Myelodysplastic Syndrome","Refractory Juvenile Myelomonocytic Leukemia"],"enrollment":36,"completionDate":"2026-06-30"},{"nctId":"NCT06716645","phase":"PHASE4","title":"A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin","status":"COMPLETED","sponsor":"HALEON","startDate":"2024-12-04","conditions":["Common Cold","Cough"],"enrollment":244,"completionDate":"2025-02-14"},{"nctId":"NCT07268248","phase":"NA","title":"1-hour Premedication for Allergy Goal in Emergency: PAGE-1 Study","status":"NOT_YET_RECRUITING","sponsor":"Paul Peng, MD PhD MSCR","startDate":"2026-06","conditions":["Allergic Reaction to Contrast Media","Hypersensitivity Reaction","Computed Tomography","Premedication"],"enrollment":540,"completionDate":"2028-06"},{"nctId":"NCT03165721","phase":"PHASE2","title":"A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-08-16","conditions":["Paraganglioma","Gastrointestinal Stromal Tumors","Carcinoma, Renal Cell","Renal Neoplasms","Pheochromocytoma"],"enrollment":9,"completionDate":"2020-02-24"},{"nctId":"NCT06049797","phase":"","title":"A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats","status":"ACTIVE_NOT_RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2023-11-15","conditions":["Hot Flashes"],"enrollment":999,"completionDate":"2026-05-31"},{"nctId":"NCT07416968","phase":"PHASE4","title":"Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2025-09-01","conditions":["Overactive Bladder (OAB)","Overactive Bladder Syndrome"],"enrollment":480,"completionDate":"2026-12"},{"nctId":"NCT07403643","phase":"PHASE4","title":"Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria","status":"NOT_YET_RECRUITING","sponsor":"Curtin University","startDate":"2026-04","conditions":["Uncomplicated Malaria"],"enrollment":60,"completionDate":"2026-12"},{"nctId":"NCT07208799","phase":"PHASE2","title":"Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures","status":"RECRUITING","sponsor":"Nishtar Medical University","startDate":"2026-01-03","conditions":["Mandible Fracture","Edema Face","Pain Management","Corticosteroid Injection"],"enrollment":72,"completionDate":"2026-12-01"},{"nctId":"NCT07305298","phase":"","title":"Mirabegron in Patients With Age-Related Macular Degeneration","status":"NOT_YET_RECRUITING","sponsor":"University of Naples","startDate":"2026-04-01","conditions":["Dry AMD","Overactive Bladder"],"enrollment":312,"completionDate":"2026-12-01"},{"nctId":"NCT07385755","phase":"NA","title":"Desvenlafaxine for Preventive Treatment of Frequent Migraines","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tongji Hospital","startDate":"2026-01-01","conditions":["Migraine"],"enrollment":440,"completionDate":"2028-01-01"},{"nctId":"NCT07378228","phase":"NA","title":"Weak Pulse at Yang and Wiry Pulse at Yin Theory","status":"COMPLETED","sponsor":"Xikun Li","startDate":"2023-07-01","conditions":["Coronary Heart Disease","Stable Angina Pectoris"],"enrollment":70,"completionDate":"2024-06-01"},{"nctId":"NCT04434664","phase":"PHASE4","title":"BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-12-01","conditions":["Heart Failure With Preserved Ejection Fraction","Hypertension"],"enrollment":50,"completionDate":"2024-12-20"},{"nctId":"NCT05092386","phase":"PHASE1","title":"Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine","status":"COMPLETED","sponsor":"Sinovac Life Sciences Co., Ltd.","startDate":"2023-01-03","conditions":["Pneumococcal Infections"],"enrollment":310,"completionDate":"2024-05-28"},{"nctId":"NCT07054801","phase":"PHASE2","title":"IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Daniel Raper, MBBS","startDate":"2026-03-01","conditions":["Headaches Associated With Subarachnoid Hemorrhage (SAH)"],"enrollment":25,"completionDate":"2027-12-01"},{"nctId":"NCT07359248","phase":"NA","title":"Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-12-01","conditions":["Tension Type Headache"],"enrollment":432,"completionDate":"2028-01-01"},{"nctId":"NCT07354529","phase":"NA","title":"Date Fruit Benefits to Treat Morning Sickness in First Trimester of Pregnancy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bahria University","startDate":"2025-06-15","conditions":["Pregnancy"],"enrollment":40,"completionDate":"2026-02-01"},{"nctId":"NCT07353749","phase":"PHASE4","title":"Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms","status":"NOT_YET_RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2026-01-30","conditions":["Unruptured Intracranial Aneurysms","Cerebrovascular Event","Hemorrhagic Stroke","Methylprednisolone","Flow Diverter"],"enrollment":864,"completionDate":"2027-09-01"},{"nctId":"NCT07317596","phase":"PHASE3","title":"Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications","status":"ENROLLING_BY_INVITATION","sponsor":"Sana'a University","startDate":"2024-06-27","conditions":["Wisdom Tooth Removal","Post Operative Complications","Hyaluronic Acid","Methylprednisolone"],"enrollment":40,"completionDate":"2026-01-08"},{"nctId":"NCT07328880","phase":"NA","title":"4-L Split-dose Polyethylene Glycol and Bisacodyl and Docusate Sodium Regimen Versus 2-L Split-dose Polyethylene Glycol Plus Oral Simethicone Regimen for Bowel Preparation Before Colonoscopy","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-04-01","conditions":["Colonoscopy Preparation"],"enrollment":450,"completionDate":"2026-04-26"},{"nctId":"NCT05931276","phase":"PHASE3","title":"CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-05-22","conditions":["End-Stage Kidney Disease","End-Stage Renal Disease"],"enrollment":2540,"completionDate":"2028-12-31"},{"nctId":"NCT07312955","phase":"NA","title":"Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2025-05-15","conditions":["Overactive Bladder"],"enrollment":80,"completionDate":"2025-11-15"},{"nctId":"NCT06437626","phase":"PHASE3","title":"Efficacy and Safety of Mexidol® in Stroke Therapy","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2019-11-18","conditions":["Ischemic Stroke"],"enrollment":304,"completionDate":"2023-08-18"},{"nctId":"NCT05761171","phase":"PHASE2","title":"A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2024-01-08","conditions":["Recurrent Acute Leukemia of Ambiguous Lineage","Recurrent Acute Lymphoblastic Leukemia","Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage","Recurrent Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged","Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia","Recurrent Mixed Phenotype Acute Leukemia","Refractory Acute Leukemia of Ambiguous Lineage","Refractory Acute Lymphoblastic Leukemia","Refractory Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage","Refractory Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged","Refractory Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia","Refractory Mixed Phenotype Acute Leukemia"],"enrollment":78,"completionDate":"2027-12-31"},{"nctId":"NCT05750459","phase":"PHASE4","title":"Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-11-29","conditions":["Plasmodium Falciparum Infection"],"enrollment":90,"completionDate":"2025-04-01"},{"nctId":"NCT07262957","phase":"PHASE4","title":"Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-09-01","conditions":["Pancreas Head Cancer","Pancreas Adenocarcinoma","IPMN, Pancreatic","Cholangio Carcinoma","Ampulla of Vater Adenocarcinoma","PDAC - Pancreatic Ductal Adenocarcinoma","Duodenal Carcinoma","Mucinous Cystic Neoplasm","Neuro Endocrine Tumours","Pancreatitis"],"enrollment":400,"completionDate":"2027-12-01"},{"nctId":"NCT06175117","phase":"PHASE4","title":"Clinical Study on the Treatment of Postpartum Anemia With Compound E Jiao Jiang(cEJJ）","status":"COMPLETED","sponsor":"DongE E Jiao Coporation Limited","startDate":"2023-01-07","conditions":["Postpartum Anemia"],"enrollment":360,"completionDate":"2025-09-08"},{"nctId":"NCT06551246","phase":"PHASE3","title":"Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-06-27","conditions":["Urinary Incontinence in Children"],"enrollment":236,"completionDate":"2027-12-01"},{"nctId":"NCT06465576","phase":"PHASE4","title":"Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-05-27","conditions":["Urinary Incontinence in Children"],"enrollment":216,"completionDate":"2027-12-01"},{"nctId":"NCT06437639","phase":"PHASE4","title":"MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG)","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2023-09-15","conditions":["Primary Open-Angle Glaucoma (POAG)"],"enrollment":80,"completionDate":"2024-02-02"},{"nctId":"NCT06903156","phase":"PHASE2","title":"Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2021-11-15","conditions":["Primary Open-Angle Glaucoma (POAG)"],"enrollment":102,"completionDate":"2023-09-07"},{"nctId":"NCT03449901","phase":"PHASE2","title":"ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2018-05-09","conditions":["Soft Tissue Sarcoma"],"enrollment":98,"completionDate":"2022-07-08"},{"nctId":"NCT07271394","phase":"","title":"The Impact of Methylprednisolone Sodium Succinate on Postoperative Delirium in Elderly Patients Undergoing Abdominal Surgery: A Target Trial Emulation Study","status":"COMPLETED","sponsor":"Chinese PLA General Hospital","startDate":"2018-10-01","conditions":["Postoperative Delirium (POD)"],"enrollment":25800,"completionDate":"2021-10-01"},{"nctId":"NCT06360458","phase":"PHASE3","title":"Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wan-Jin Chen","startDate":"2024-08-01","conditions":["Acute Ischemic Stroke","Large Infarct Core"],"enrollment":928,"completionDate":"2030-06-30"},{"nctId":"NCT07257588","phase":"NA","title":"The Efficacy of Hyperbaric Oxygen-assisted Treatment for ASUC and Refractory IBD","status":"ENROLLING_BY_INVITATION","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-09-30","conditions":["Ulcerative Colitis"],"enrollment":44,"completionDate":"2025-12-31"},{"nctId":"NCT02112916","phase":"PHASE3","title":"Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-10-04","conditions":["Adult T Acute Lymphoblastic Leukemia","Ann Arbor Stage II Adult Lymphoblastic Lymphoma","Ann Arbor Stage II Childhood Lymphoblastic Lymphoma","Ann Arbor Stage III Adult Lymphoblastic Lymphoma","Ann Arbor Stage III Childhood Lymphoblastic Lymphoma","Ann Arbor Stage IV Adult Lymphoblastic Lymphoma","Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma","Childhood T Acute Lymphoblastic Leukemia"],"enrollment":847,"completionDate":"2026-09-16"},{"nctId":"NCT07238452","phase":"PHASE4","title":"Optimising Pacing Therapy, Integrated Medical Therapy, and Catheter AbLation for Atrial Fibrillation in Heart Failure Trial","status":"NOT_YET_RECRUITING","sponsor":"University of British Columbia","startDate":"2025-12-01","conditions":["Heart Failure With Reduced Ejection Fraction","Atrial Fibrillation (AF)"],"enrollment":1056,"completionDate":"2033-01-01"},{"nctId":"NCT02883049","phase":"PHASE3","title":"Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2012-02-29","conditions":["B Acute Lymphoblastic Leukemia","B Acute Lymphoblastic Leukemia, BCR-ABL1-Like","Central Nervous System Leukemia","Testicular Leukemia"],"enrollment":5949,"completionDate":"2026-10-03"},{"nctId":"NCT06489951","phase":"NA","title":"Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker","status":"COMPLETED","sponsor":"Xing Liu","startDate":"2024-12-28","conditions":["Overactive Bladder","Pediatric Disorder"],"enrollment":180,"completionDate":"2025-07-03"},{"nctId":"NCT04633005","phase":"PHASE2","title":"Polypill Strategy for Heart Failure With Reduced Ejection Fraction","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2021-11-15","conditions":["Heart Failure"],"enrollment":212,"completionDate":"2025-10-31"},{"nctId":"NCT04980716","phase":"PHASE3","title":"Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2021-06-01","conditions":["Non-small Cell Lung Cancer","Cardiovascular Complication"],"enrollment":524,"completionDate":"2026-07-01"},{"nctId":"NCT07171320","phase":"NA","title":"The Efficacy and Safety of Pregabalin Combined With Desvenlafaxine in Patients With Fibromyalgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-15","conditions":["Fibromyalgia","Pregabalin","Pain"],"enrollment":384,"completionDate":"2027-08-31"},{"nctId":"NCT06462781","phase":"PHASE1","title":"Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1","status":"COMPLETED","sponsor":"The Cooper Health System","startDate":"2024-03-15","conditions":["Refractory Migraine"],"enrollment":10,"completionDate":"2025-06-01"},{"nctId":"NCT03401398","phase":"PHASE3","title":"Stress Hydrocortisone In Pediatric Septic Shock","status":"RECRUITING","sponsor":"Jerry Zimmerman","startDate":"2019-03-11","conditions":["Septic Shock"],"enrollment":500,"completionDate":"2026-12-31"},{"nctId":"NCT06811233","phase":"PHASE2","title":"Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-05-08","conditions":["Acute Myeloid Leukemia (AML)"],"enrollment":140,"completionDate":"2031-08-31"},{"nctId":"NCT05019027","phase":"PHASE4","title":"N-of-1 for Beta-Blockers in Cardiac Amyloidosis","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2024-01-31","conditions":["Cardiac Amyloidosis","Heart Diseases","TTR Cardiac Amyloidosis"],"enrollment":20,"completionDate":"2026-12-31"},{"nctId":"NCT05585125","phase":"PHASE4","title":"A Preliminary Study for INFORMED","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2024-02-07","conditions":["Heart Failure","Heart Failure, Diastolic","Heart Failure With Preserved Ejection Fraction","Cardiac Failure","Heart Diseases"],"enrollment":20,"completionDate":"2026-07"},{"nctId":"NCT06834490","phase":"PHASE3","title":"Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2019-11-05","conditions":["Chronic Cerebral Ischemia"],"enrollment":318,"completionDate":"2020-12-08"},{"nctId":"NCT07202143","phase":"PHASE3","title":"Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia","status":"RECRUITING","sponsor":"YiLin","startDate":"2025-09-01","conditions":["Large Infarct Core","Post-stroke Lymphocytopenia"],"enrollment":200,"completionDate":"2027-09-30"},{"nctId":"NCT07185633","phase":"PHASE2","title":"Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host Disease","status":"NOT_YET_RECRUITING","sponsor":"Bin Gu","startDate":"2025-10-01","conditions":["aGVHD"],"enrollment":25,"completionDate":"2027-10-01"},{"nctId":"NCT06964464","phase":"PHASE4","title":"Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator","status":"RECRUITING","sponsor":"University of Rochester","startDate":"2025-08-17","conditions":["Heart Failure With Reduced Ejection Fraction (HFrEF)","Sudden Cardiac Death","Ventricular Arrhythmia","Implantable Cardioverter Defibrillator (ICD)","Beta-blocker Therapy","Cardiomyopathy"],"enrollment":2000,"completionDate":"2031-07-01"},{"nctId":"NCT07141303","phase":"PHASE3","title":"Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-08-08","conditions":["Acute Ischemic Stroke"],"enrollment":1060,"completionDate":"2028-06-30"},{"nctId":"NCT07180277","phase":"PHASE4","title":"Methylprednisolone for Moderate to Severe Traumatic Brain Injury","status":"NOT_YET_RECRUITING","sponsor":"Zhangjiagang First People's Hospital","startDate":"2025-10-01","conditions":["Traumatic Brain Injury"],"enrollment":520,"completionDate":"2028-03-01"},{"nctId":"NCT07175649","phase":"NA","title":"Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STroke","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-10","conditions":["Ischemic Stroke, Acute"],"enrollment":912,"completionDate":"2029-12"},{"nctId":"NCT04546399","phase":"PHASE2","title":"A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-12-17","conditions":["Down Syndrome","Recurrent B Acute Lymphoblastic Leukemia"],"enrollment":461,"completionDate":"2028-06-30"},{"nctId":"NCT06803030","phase":"PHASE3","title":"Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms","status":"RECRUITING","sponsor":"Bir Hospital","startDate":"2025-08-30","conditions":["Ureteral Stent-Related Symptom"],"enrollment":189,"completionDate":"2026-12-31"},{"nctId":"NCT05290285","phase":"NA","title":"Amino Acids in Patients With Anorexia Nervosa: Double-blind Randomized Study Versus Placebo","status":"RECRUITING","sponsor":"Villa Garda Hospital","startDate":"2022-07-01","conditions":["Anorexia Nervosa"],"enrollment":92,"completionDate":"2027-01-01"},{"nctId":"NCT04914234","phase":"PHASE4","title":"Premedication With Atenolol Versus Metoprolol for Controlled Hypotensive Anesthesia During Nasal Surgeries","status":"RECRUITING","sponsor":"Damanhour Teaching Hospital","startDate":"2025-08-01","conditions":["Hypotension Drug-Induced"],"enrollment":60,"completionDate":"2026-01-30"},{"nctId":"NCT07130175","phase":"NA","title":"Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)","status":"COMPLETED","sponsor":"Qian Feng","startDate":"2022-12-31","conditions":["Polymorphic Ventricular Tachycardia","Heart Failure"],"enrollment":118,"completionDate":"2024-12-31"},{"nctId":"NCT06854601","phase":"PHASE3","title":"Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2019-07-13","conditions":["Attention Deficit Hyperactivity Disorder (ADHD)","Anxiety Disorders and Symptoms"],"enrollment":333,"completionDate":"2020-07-13"},{"nctId":"NCT05935787","phase":"PHASE3","title":"Cytoflavin in the Complex Rehabilitation of Stroke Patients","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-06-09","conditions":["Stroke"],"enrollment":240,"completionDate":"2024-12-07"},{"nctId":"NCT07116811","phase":"PHASE3","title":"Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-01","conditions":["Vestibular Schwannoma","Facial Nerve Paralysis"],"enrollment":364,"completionDate":"2027-09-30"},{"nctId":"NCT07114640","phase":"PHASE3","title":"The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Far Eastern Memorial Hospital","startDate":"2025-08-07","conditions":["Urinary Bladder, Overactive"],"enrollment":220,"completionDate":"2028-12-31"},{"nctId":"NCT07114848","phase":"PHASE4","title":"Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.","status":"COMPLETED","sponsor":"Liaquat National Hospital & Medical College","startDate":"2024-06-13","conditions":["Ureteral Stent-Related Symptom","Alpha Blocker","Anticholinergics","Ureter Calculi"],"enrollment":60,"completionDate":"2025-03-30"},{"nctId":"NCT05682261","phase":"NA","title":"The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age","status":"COMPLETED","sponsor":"Ethiopian Public Health Institute","startDate":"2023-03-23","conditions":["Anemia"],"enrollment":265,"completionDate":"2023-10-17"},{"nctId":"NCT07074834","phase":"NA","title":"Metoprolol and Trimetazidine for Coronary Heart Disease With Angina","status":"COMPLETED","sponsor":"Shiyan City Renmin Hospital","startDate":"2021-02-01","conditions":["Coronary Heart Disease (CHD)"],"enrollment":102,"completionDate":"2022-12-31"},{"nctId":"NCT04220229","phase":"PHASE1,PHASE2","title":"Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities","status":"TERMINATED","sponsor":"University of Washington","startDate":"2020-06-01","conditions":["Sarcoma of the Extremity","Stage I Soft Tissue Sarcoma of the Trunk and Extremities","Stage IA Soft Tissue Sarcoma of the Trunk and Extremities","Stage IB Soft Tissue Sarcoma of the Trunk and Extremities","Stage II Soft Tissue Sarcoma of the Trunk and Extremities"],"enrollment":6,"completionDate":"2024-10-31"},{"nctId":"NCT04979650","phase":"PHASE2","title":"Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2021-05-22","conditions":["Multiple Sclerosis, Relapsing-Remitting","Magnetic Resonance Imaging","Methylprednisolone"],"enrollment":102,"completionDate":"2023-12-29"},{"nctId":"NCT05273996","phase":"PHASE4","title":"Predictors of Cognitive Outcomes in Geriatric Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"David Steffens","startDate":"2021-09-28","conditions":["Major Depressive Disorder","Neuroticism","Cognitive Change","Stress"],"enrollment":75,"completionDate":"2026-06-30"},{"nctId":"NCT03718234","phase":"PHASE1","title":"Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-01-01","conditions":["Congenital Adrenal Hyperplasia","Hyperplasia","Adrenal Hyperplasia","Congenital Disorders","Adrenocortical Hyperfunction","Disorders of Sex Development","Urogenital Abnormalities","Genetic Diseases, Inborn","Steroid Metabolic Diseases, Inborn","Adrenal Gland Disease","Hydrocortisone"],"enrollment":11,"completionDate":"2023-02-23"},{"nctId":"NCT00001337","phase":"PHASE2","title":"Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1993-05-08","conditions":["Diffuse Large B-Cell Lymphoma (DLBCL)","Primary Mediastinal Large B-cell Lymphoma","Burkitt Lymphoma","Anaplastic Large-Cell Lymphoma","Gray Zone Lymphoma"],"enrollment":348,"completionDate":"2024-05-24"},{"nctId":"NCT07025876","phase":"EARLY_PHASE1","title":"PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine","status":"COMPLETED","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2023-11-18","conditions":["Streptococcus Pneumoniae Pneumonia"],"enrollment":240,"completionDate":"2024-07-30"},{"nctId":"NCT07025642","phase":"NA","title":"Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes","status":"RECRUITING","sponsor":"Mackay Medical College","startDate":"2025-07-01","conditions":["Overactive Bladder (OAB)"],"enrollment":60,"completionDate":"2026-12-01"},{"nctId":"NCT05714007","phase":"PHASE4","title":"The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-08-31","conditions":["Perioperative Anemia","Surgery","Spinal Deformity","Adult"],"enrollment":120,"completionDate":"2025-12"},{"nctId":"NCT00476190","phase":"PHASE2","title":"ALL Adult Consortium Trial: Adult ALL Trial","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2007-04","conditions":["Acute Lymphoblastic Leukemia"],"enrollment":112,"completionDate":"2020-03"},{"nctId":"NCT03778554","phase":"PHASE4","title":"Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bispebjerg Hospital","startDate":"2018-12-17","conditions":["Acute Myocardial Infarction","Non-ST Elevation Myocardial Infarction (nSTEMI)","ST Elevation Myocardial Infarction"],"enrollment":2760,"completionDate":"2035-12-10"},{"nctId":"NCT03646357","phase":"PHASE4","title":"BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oslo University Hospital","startDate":"2018-10-01","conditions":["Acute Myocardial Infarction","Non-ST Elevation Myocardial Infarction","ST Elevation Myocardial Infarction"],"enrollment":2895,"completionDate":"2035-12-10"},{"nctId":"NCT06984432","phase":"NA","title":"Evaluation of a Non-cross-linked Hyaluronic Acid Medical Device (\"Electri\" and \"XELA REDERM\") for Improving Facial Skin Appearance","status":"COMPLETED","sponsor":"Institute Hyalual GmbH","startDate":"2021-03-30","conditions":["Appearance of Facial Wrinkles","Aesthetic","Hydration","Facial Skin Wrinkles"],"enrollment":77,"completionDate":"2021-10-29"},{"nctId":"NCT06374641","phase":"NA","title":"The Effects of a Novel Mitochondrial Substrate Supplement on Exercise Performance and Cognitive Function","status":"RECRUITING","sponsor":"University of Exeter","startDate":"2024-03-26","conditions":["Exercise Performance","Cognitive Function"],"enrollment":40,"completionDate":"2025-10"},{"nctId":"NCT05798403","phase":"NA","title":"Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder","status":"RECRUITING","sponsor":"Yin Ping","startDate":"2023-07-07","conditions":["Overactive Bladder"],"enrollment":204,"completionDate":"2025-12-31"},{"nctId":"NCT05968885","phase":"PHASE4","title":"Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2021-10-01","conditions":["Urinary Bladder, Overactive","Urodynamics","Effect of Drug"],"enrollment":300,"completionDate":"2026-12-31"},{"nctId":"NCT06479720","phase":"PHASE4","title":"Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2022-06-16","conditions":["Effect of Drug","Urinary Bladder, Overactive"],"enrollment":300,"completionDate":"2026-12-31"},{"nctId":"NCT06197295","phase":"PHASE4","title":"Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor Overactivity","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2022-06-16","conditions":["Urinary Bladder, Overactive","Effect of Drug"],"enrollment":200,"completionDate":"2026-12-31"},{"nctId":"NCT05767346","phase":"PHASE3","title":"Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM","status":"COMPLETED","sponsor":"Cytokinetics","startDate":"2023-06-20","conditions":["Obstructive Hypertrophic Cardiomyopathy (oHCM)"],"enrollment":175,"completionDate":"2025-03-28"},{"nctId":"NCT06955533","phase":"NA","title":"Single Dose Versus Double Dose Tamsulosin 0.4 and Solifenacin 5 in Management of Stent Related Symptoms","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-04-01","conditions":["Stent Related Symptoms"],"enrollment":64,"completionDate":"2024-08-01"},{"nctId":"NCT06183242","phase":"PHASE2,PHASE3","title":"Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-05-27","conditions":["Cholestasis, Intrahepatic"],"enrollment":328,"completionDate":"2024-10-10"},{"nctId":"NCT06221826","phase":"PHASE4","title":"MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2023-04-17","conditions":["Ischemic Stroke, Acute"],"enrollment":60,"completionDate":"2023-09-12"},{"nctId":"NCT05928286","phase":"","title":"Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice","status":"RECRUITING","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2022-12-01","conditions":["Gallstone Disease","Obstructive Jaundice"],"enrollment":286,"completionDate":"2025-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Tablet","formulations":[{"form":"TABLET","route":"ORAL","productName":"Niferex"}]},"crossReferences":{"NUI":"N0000178335","MMSL":"NOCODE","NDDF":"002404","UNII":"AB6MNQ6J6L","VUID":"4028568","CHEBI":"CHEBI:15741","VANDF":"4028568","RXNORM":"37255","UMLSCUI":"C0075429","chemblId":"CHEMBL576","ChEMBL_ID":"CHEMBL576","DRUGBANK_ID":"DB00139","PDB_CHEM_ID":" SIN","PUBCHEM_CID":"1110","SNOMEDCT_US":"60376006","IUPHAR_LIGAND_ID":"3637","MESH_DESCRIPTOR_UI":"D019802"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":4591,"therapeuticAreas":["Hematology"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Butanedioic acid, also known as succinic acid, is a small molecule. It is being studied in clinical trials for various conditions, including ischemic stroke, hypertension, and neuromyelitis optica spectrum disorder.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:55:33.587985+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}